<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2805245371
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Hydroxychloroquine SAJA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROXYCHLOROQUINE SULFATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        71.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        P01BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Hydroxychloroquine SAJA contains a medicine called hydroxychloroquine<br />sulphate.<br />&bull; Hydroxychloroquine SAJA works by reducing inflammation in people with<br />autoimmune &nbsp;diseases &nbsp;)this &nbsp;is &nbsp;where &nbsp;the &nbsp;body&rsquo;s &nbsp;immune &nbsp;system &nbsp;attacks<br />itself &nbsp;by &nbsp;mistake(<br /><strong>It can be used for:</strong><br />&bull; Rheumatoid arthritis )inflammation of the joints(<br />&bull; Juvenile idiopathic arthritis )inflammation of the joints(<br />&bull; Discoid and systemic lupus erythematosus )a disease of the skin or internal<br />organs(<br />&bull; Skin problems which are sensitive to sunlight<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Hydroxychloroquine SAJA and tell your doctor if:</strong><br />&bull; You are allergic )hypersensitive( to:<br />- Hydroxychloroquine<br />- Other similar medicines such as quinolones and quinine<br />- Any of the other ingredients of Hydroxychloroquine SAJA )listed in Section<br />6 below(.<br /><strong>Signs &nbsp;of &nbsp;an &nbsp;allergic &nbsp;reaction &nbsp;include:</strong> &nbsp;a rash, swallowing or breathing<br />problems, swelling of your lips, face, throat or tongue<br />&bull; You have an eye problem which affects the retina, the inside of the eye<br />)maculopathy( or you get a change in eye color or any other eye problem<br />&bull; You are pregnant, might become pregnant or think you may be pregnant<br />)see &lsquo;Pregnancy and breast-feeding&rsquo; below(<br />&bull; Hydroxychloroquine SAJA should not be used in children under 6 years of<br />age or below 35 kg.<br />Do not take this medicine if any of the above apply to you. If you are not<br />sure, talk to your doctor or pharmacist before taking Hydroxychloroquine<br />SAJA.<br /><strong>Appropriate precautions for use; Special warnings:</strong><br /><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Hydroxychloroquine SAJA if<br />&bull; You have liver or kidney problems<br />&bull; You have serious stomach or gut problems<br />&bull; You are taking a drug called Tamoxifen, used to treat breast cancer<br />&bull; You have any problems with your blood. You may have blood tests to check<br />this<br />&bull; You have heart problems )signs include breathlessness and chest pain(<br />which may require monitoring<br />&bull; You have any problems with your nervous system or brain<br />&bull; You have psoriasis )red scaly patches on the skin usually affecting the<br />knees, elbows and scalp(<br />&bull; You have had a bad reaction to quinine in the past<br />&bull; &nbsp;You &nbsp;have &nbsp;a &nbsp;genetic &nbsp;condition &nbsp;known &nbsp;as &nbsp;&lsquo;glucose-6-dehydrogenase<br />deficiency<br />&bull; You have a rare illness called &lsquo;porphyria&rsquo; which affects your metabolism<br />&bull; Hydroxychloroquine can cause lowering of the blood glucose level. Please<br />ask your doctor to inform you of signs and symptoms of low blood glucose<br />levels. A check of the blood glucose level may be necessary<br /><strong>Before treatment with Hydroxychloroquine SAJA</strong><br />&bull; Before you take this medicine you should have your eyes examined<br />&bull; This testing should be repeated at least every 12 months whilst taking<br />Hydroxychloroquine &nbsp;SAJA<br />&bull; If you are over 65, need to take a high dose )2 tablets a day( or have kidney<br />problems then this examination should be performed more often.<br />If you are not sure if any of the above applies to you, talk to your doctor or<br />pharmacist before taking Hydroxychloroquine SAJA<br /><strong>Children</strong><br />Hydroxychloroquine SAJA should not be used in children under 6 years of<br />age or below 35kg. Small children are particularly sensitive to the toxic<br />effect of quinolones, so Hydroxychloroquine SAJA should be kept out of the<br />reach of children.<br /><strong>Other medicines and Hydroxychloroquine SAJA</strong><br />Please &nbsp;tell &nbsp;your &nbsp;doctor &nbsp;or &nbsp;pharmacist &nbsp;if &nbsp;you &nbsp;are &nbsp;taking, &nbsp;have &nbsp;recently<br />taken &nbsp;or &nbsp;might &nbsp;use &nbsp;any &nbsp;other &nbsp;medicines. &nbsp;This &nbsp;includes &nbsp;medicines &nbsp;you<br />buy &nbsp;without &nbsp;a &nbsp;prescription, &nbsp;including &nbsp;herbal &nbsp;medicines. &nbsp;This &nbsp;is &nbsp;because<br />Hydroxychloroquine SAJA can affect the way some other medicines work<br />Also, some medicines can affect the way Hydroxychloroquine SAJA works. In<br />particular, tell your doctor if you are taking any of the following:<br /><strong>The following medicines may increase the chance of you getting side<br />effects when taken with Hydroxychloroquine SAJA:</strong><br />&bull; Some antibiotics used for infections )such as gentamicin, neomycin or<br />tobramycin(<br />&bull; Cimetidine &ndash; used for stomach ulcers<br />&bull; Neostigmine and pyridostigmine &ndash; used for muscle weakness )myasthenia<br />gravis(<br />&bull; Medicines that may affect the kidney or liver<br />&bull; Medicines that affect the skin or the eyes<br />&bull; &nbsp;Medicines &nbsp;used &nbsp;to &nbsp;treat &nbsp;malaria &nbsp;)such &nbsp;as &nbsp;halofantrine, &nbsp;mefloquine<br />moxifloxacin(<br />&bull; Some medicines used to treat arrhythmias )amiodarone(<br /><strong>The &nbsp;following &nbsp;medicines &nbsp;can &nbsp;change &nbsp;the &nbsp;way &nbsp;Hydroxychloroquine<br />SAJA works or Hydroxychloroquine SAJA may affect the way some of<br />these &nbsp;medicines &nbsp;work:</strong><br />&bull; Digoxin &ndash; used for heart problems<br />&bull; Medicines for epilepsy<br />&bull; Medicines for diabetes )such as insulin or metformin(<br />&bull; Antacids &ndash; used for heartburn or indigestion.<br /><strong>You &nbsp;should &nbsp;leave &nbsp;a &nbsp;gap &nbsp;of &nbsp;at &nbsp;least &nbsp;4 &nbsp;hours &nbsp;between &nbsp;taking &nbsp;these<br />medicines &nbsp; and &nbsp; Hydroxychloroquine &nbsp; SAJA.</strong><br />&bull; Rabies vaccine<br />&bull; Praziquantel<br />&bull; Ciclosporin<br />&bull; Agalsidase<br /><strong>Pregnancy and breast-feeding</strong><br />Do not take Hydroxychloroquine SAJA if<br />&bull; You are pregnant, might become pregnant or think you may be pregnant<br />&bull; You are breast-feeding or planning to breast-feed. This is because small<br />amounts may pass into mothers&rsquo; milk<br />Ask your doctor or pharmacist for advice before taking any medicine if you<br />are pregnant or breast-feeding.<br />Driving and using machines<br />You may get eye problems while taking this medicine. If this happens, do<br />not drive or use any tools or machines, and tell your doctor straight away<br />Important information about some of the ingredients of Hydroxychloroquin<br />SAJA<br />This &nbsp;medicine &nbsp;contains &nbsp;lactose. &nbsp;If &nbsp;you &nbsp;have &nbsp;been &nbsp;told &nbsp;by &nbsp;your &nbsp;doctor<br />that you can not tolerate some sugars, talk to your doctor before taking<br />Hydroxychloroquine &nbsp; &nbsp;SAJA<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Hydroxychloroquine SAJA exactly as your doctor has told you.<br />Your doctor will decide your daily dose. You should check with your doctor or<br />pharmacist if you are not sure.<br /><strong>Taking this medicine</strong><br />&bull; Take this medicine by mouth<br />&bull; Swallow the tablets whole with a meal or a glass of milk. Do not crush or<br />chew your tablets.<br />&bull; If you are taking this medicine for skin problems that are sensitive<br />to sunlight, only take Hydroxychloroquine SAJA during periods of high<br />exposure to light<br />&bull; The doctor will work out the dose depending on your body weight. If you<br />feel the effect of your medicine is too weak or too strong, do not change the<br />dose yourself, but ask your doctor<br />&bull; If you have been taking this medicine for rheumatoid arthritis for a long<br />time )more than 6 months( and you do not feel that it is helping you, see<br />your doctor. This is because the treatment may need to be stopped.<br /><strong>How much to take</strong><br /><strong>&bull; Adults including the elderly</strong><br />- One or two tablets each day<br /><strong>&bull; Children and adolescents</strong><br />- One tablet each day<br />- This medicine is only suitable for children who weigh more than 35kg.<br />It may take several weeks before you notice the benefit of taking<br />Hydroxychloroquine SAJA.<br /><strong>If you take more Hydroxychloroquine SAJA than you should</strong><br />&bull; If you take more Hydroxychloroquine SAJA than you should, tell a doctor or<br />go to a hospital casualty department straight away. Take the medicine with<br />you. This is so the doctor knows what you have taken.<br />&bull; The following effects may happen: headache, problems with your<br />eyesight, fall in blood pressure, convulsions, heart problems, followed by<br />sudden severe breathing problems and possibly heart attack. Overdose of<br />Hydroxychloroquine SAJA may have a fatal outcome<br />&bull; Young children and babies are particularly at risk if they accidentally take<br />Hydroxychloroquine SAJA. Take the child to a hospital straight away<br /><strong>If you forget to take Hydroxychloroquine SAJA</strong><br />If you forget a dose, take it as soon as you remember it. However, if it is<br />nearly time for the next dose, skip the missed dose. Do not take a double<br />dose to make up for a forgotten dose.<br /><strong>If you stop taking Hydroxychloroquine SAJA</strong><br />Keep taking your medicine until your doctor tells you to stop. Do not stop<br />taking Hydroxychloroquine SAJA just because you feel better. If you stop,<br />your illness may get worse again.<br /><strong>If you have any further questions on the use of this product, ask your<br />doctor or pharmacist.</strong><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Hydroxychloroquine SAJA can cause side effects,<br />although not everybody gets them.<br /><strong>Stop taking Hydroxychloroquine SAJA and see a doctor or go to a<br />hospital straight away if:</strong><br />&bull; You have an allergic reaction. The signs may include: a red or lumpy rash,<br />swallowing or breathing problems, swelling of your eyelids, lips, face, throat<br />or tongue.<br /><strong>Stop taking Hydroxychloroquine SAJA and see a doctor straight away<br />if you notice any of the following serious side effects &ndash; you may need<br />urgent medical treatment:</strong><br />&bull; A small number of people being treated with Hydroxychloroquine SAJA<br />have had thoughts of harming or killing themselves. If at any time you have<br />these thoughts, immediately contact your doctor.<br />&bull; You have any eye problems. This includes changes in the colour of your eye<br />and problems with your eyesight such as blurring, sensitivity to light or the<br />way you see colour.<br />&bull; You have any muscle weakness, cramps, stiffness or spasms or changes in<br />sensation such as tingling.<br />&bull; If you take this medicine for a long time, your doctor will occasionally check<br />your muscles and tendons to make sure they are working properly.<br />&bull; Severe skin reactions such as blistering, widespread scaly skin, pus-filled<br />spots together with a high temperature.<br />&bull; Blistering or peeling of the skin around the lips, eyes, mouth, nose and<br />genitals, u-like symptoms and fever. This could be a condition called<br />Stevens-Johnson syndrome.<br />&bull; Multiple skin lesions, itching of the skin, joint aches, fever and a general ill<br />feeling. This could be a condition called Toxic Epidermal Necrolysis.<br />&bull; You may get infections more easily than usual. This could be due to bone<br />marrow depression or a blood disorder called &lsquo;agranulocytosis&rsquo;.<br />&bull; You may bruise more easily than usual. This could be due to a blood problem<br />called &lsquo;thrombocytopenia&rsquo;.<br />&bull; You feel tired, faint or dizzy and have pale skin. These could be symptoms<br />of something called &lsquo;anaemia&rsquo;.<br />&bull; You feel weak, short of breath, bruise more easily than usual and get<br />infections more easily than usual. These could be symptoms of something<br />called &lsquo;aplastic anaemia&rsquo;.<br />&bull; Liver problems that may cause the eyes or skin to go yellow )jaundice(.<br /><strong>Tell your doctor or pharmacist if any of the following side effects get<br />serious or lasts longer than a few days:</strong><br />&bull; Skin rashes, itching, changes in the colour of your skin or the inside of your<br />nose or mouth.<br />&bull; Psoriasis )red scaly patches on the skin usually affecting the knees,<br />elbows and scalp(.<br />&bull; Hair loss or loss of hair colour.<br />&bull; Feeling or being sick, diarrhoea, loss of appetite )anorexia( or stomach<br />pain.<br />&bull; Feeling nervous, ringing in the ear )tinnitus(, hearing loss, headache,<br />balance problems )vertigo( or feeling dizzy, mental problems )such as<br />delusions, hallucinations or changes in mood(.<br />&bull; Weakening of the heart muscle )cardiomyopathy( resulting in difficulty in<br />breathing, coughing, high blood pressure, swelling, increased heart rate, low<br />amount of urine.<br />&bull; You may get infections more easily than usual. This could be due to bone<br />marrow depression.<br />&bull; Symptoms of a condition called &lsquo;porphyria&rsquo; which may include stomach<br />pain, being sick, blisters, itching.<br />&bull; Symptoms of lowering of the blood glucose level )hypoglycaemia(. You may<br />feel a sense of nervousness, shaky or sweaty.<br />&bull; Trembling, muscle spasm or irregular jerky movements .<br /><strong>Blood Tests</strong><br />&bull; Periodic blood counts are advised for patients on long-term therapy and<br />Hydroxychloroquine SAJA should be discontinued if abnormalities occur.<br />&bull; A blood test may show changes in the way the liver is working and<br />occasionally the liver may stop working.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the carton<br />after EXP. The expiry date refers to the last day of that month.<br />Do not store above 30&deg;C.<br />Store in the original package in order to protect from light and moisture.<br />Do not throw away any medicines via wastewater or household waste. Ask<br />your pharmacist how to throw away medicines you no longer use. These<br />measures will help protect the environment.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active substance is:</strong><br />Hydroxychloroquine. Each film coated tablet contains 200 mg of<br />Hydroxychloroquine<br /><strong>The other ingredients are :</strong><br />- Corn Starch<br />- Polyvinyl Pyrolidone )Povidone K30(<br />- Lactose monohydrate<br />- Magnesium Stearate<br />- Opadry II white 32F280000<br />- Purified water<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                -Hydroxychloroquine SAJA is White biconvex rounded film coated tablet
coded with "E" on one side and plain on the other.
-Hydroxychloroquine SAJA is provided in pack containing 60 tablets in PVCPVDC\Alu blisters )15’s\blister(
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SAJA Pharmaceuticals<br />Saudi Arabian Japanese pharmaceutical company limited<br />Jeddah &ndash; Kingdom of Saudi Arabia<br />&nbsp;</p><p><strong>-To report any side effect (s)</strong><br /><strong>&bull; Saudi Arabia</strong><br />- The National Pharmacovigilance Centre )NPC(:<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br /><strong>&bull; Other GCC states /other countries</strong><br />-Please contact the relevant competent authority.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December /2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&bull; يحتوي هيدروكـسيكلوروكين ساجا على دواء يُسمّى سلفات الهيدروكسيكلوروكين.</p><p dir="RTL">&bull; يعمل هيدروكـسيكلوروكين ساجا عبر تخفيف الالتهاب لدى الأشخاص المصابين بأمراض ذاتيّة المناعة (أيّ عندما يهاجم جهاز المناعة في الجسم نفسه عن طريق الخطأ).</p><p dir="RTL"><strong>يمكن استعماله لعلاج ما يلي</strong><strong>:</strong></p><p dir="RTL">- التهاب المفاصل الروماتويدي (التهاب المفاصل)</p><p dir="RTL">- التهاب المفاصل المجهول السبب لدى الأطفال (التهاب المفاصل)</p><p dir="RTL">- الذأب الحُمامي القرصي والمجموعي (مرض في الجلد أو في الأعضاء الداخليّة)</p><p dir="RTL">- المشاكل الجلديّة الحسّاسة تجاه أشعّة الشمس</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع الاستعمال</strong></p><p dir="RTL">لا تتناول هيدروكـسيكلوروكين ساجا وأعلم طبيبك:</p><p dir="RTL">&bull; إذا كنت تعاني من حساسيّة ضدّ:</p><p dir="RTL">- الهيدروكسيكلوروكين</p><p dir="RTL">- أدوية مماثلة أخرى مثل الكينولونات والكينين</p><p dir="RTL">- أيّ مكوّن من المكوّنات الأخرى في هيدروكـسيكلوروكين ساجا (المذكورة في القسم 6 أدناه)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تتضمّن عوارض الارتكاس التحسّسي ما يلي:</strong> طفح ومشاكل في البلع أو التنفّس وتورّم الشفتين أو الوجه أو الحلق أو اللسان.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; إذا كنت تعاني من مشكلة في العينين تؤثّر على الشبكيّة، داخل العين (بقعة الشبكيّة) أو تغيّر لون عينيك أو كنت تعاني من أيّ مشكلة أخرى في العينين</p><p dir="RTL">&bull; إذا كنتِ حاملاً أو قد تُصبحين حاملاً أو تعتقدين نفسك حاملاً (راجعي فقرة &quot;الحمل والإرضاع&quot; أدناه)</p><p dir="RTL">&bull; لا ينبغي استعمال هيدروكـسيكلوروكين ساجا لدى الأطفال ما دون السادسة من العمر أو لدى الذين يقلّ وزنهم عن 35 كلغ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لا تتناول هذا الدواء إذا كانت تنطبق عليك إحدى الحالات أعلاه. في حال الشكّ، استشر الطبيب أو الصيدلي قبل تناول هيدروكـسيكلوروكين ساجا</strong><strong>. </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>احتياطات مناسبة للاستعمال؛ تحذيرات خاصة</strong><strong>:</strong></p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدّث إلى الطبيب أو الصيدلي قبل أخذ هيدروكـسيكلوروكين ساجا إذا:</p><p dir="RTL">&bull; كنت تعاني من مشاكل في الكبد أو الكليتين.</p><p dir="RTL">&bull; كنت تعاني من مشاكل خطيرة في المعدة أو الأمعاء.</p><p dir="RTL">&bull; كنت تأخذ دواء يُسمّى تاموكسيفين، يُستعمل لعلاج السرطان.</p><p dir="RTL">&bull; كنت تعاني من مشاكل في الدم. يمكنك الخضوع لفحوصات دم للتحقق من هذا الأمر.</p><p dir="RTL">&bull; كنت تعاني من مشاكل في القلب (تتضمّن الإشارات ضيق النفس وألم الصدر) قد تتطلّب مراقبة.</p><p dir="RTL">&bull; كنت تعاني من أيّ مشكلة في جهازك العصبي أو دماغك</p><p dir="RTL">&bull; كنت تعاني من داء الصّدفية (لطخات حمراء حرشفيّة على الجلد تُصيب عادة الركبتَيْن والمرفَقَيْن وفروة الرأس)</p><p dir="RTL">&bull; تعرّضت لردّة فعل سيّئة تجاه الكينين في الماضي</p><p dir="RTL">&bull; كنت مصابًا بحالة وراثيّة تُعرف &quot;بنقص نازعة هدروجين الغلوكوز &ndash; 6&quot;</p><p dir="RTL">&bull; كنت مصابًا بمرض نادر يُدعى &quot;برفيريّة&quot; يُصيب الأيض لديك</p><p dir="RTL">&bull; يمكن أن يسبّب الهيدروكسيكلوروكين انخفاضًا في مستوى غلوكوز الدم. اطلب رجاء من طبيبك بأن يُعلمك بإشارات وعوارض مستويات غلوكوز الدم المنخفضة. قد يكون من الضروريّ فحص مستوى غلوكوز الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قبل العلاج بهيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">&bull; قبل أن تتناول هذا الدواء يجب أن تفحص عينيك.</p><p dir="RTL">&bull; يجب تكرار هذا الفحص كلّ 12 شهرًا على الأقلّ في خلال مدّة العلاج هيدروكـسيكلوروكين ساجا.</p><p dir="RTL">&bull; إذا كنت فوق الـ65 من العمر أو كنت بحاجة لأخذ جرعة عالية (قرصين في اليوم) أو كنت تعاني من مشاكل كلويّة يجب إجراء هذا الفحص لمرّات أكثر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا لم تكن متأكّدًا مما إذا كانت إحدى الحالات أعلاه تنطبق عليك، تحدّث إلى الطبيب أو الصيدلي قبل أخذ هيدروكـسيكلوروكين ساجا</strong><strong>.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا ينبغي استعمال هيدروكـسيكلوروكين ساجا لدى الأطفال ما دون عمر 6 سنوات أو الذين يقلّ وزنهم عن 35 كلغ. يتأثّر الأطفال الصغار بشكل خاص بالمفعول السمّي للكينولونات، لذا يجب حفظ هيدروكـسيكلوروكين ساجا بعيدًا عن متناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أدوية أخرى وهيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">الرجاء أن تُعلم الطبيب أو الصيدلي إذا كنت تتناول حاليًّا أو تناولت مؤخّرًا أو قد تستعمل أيّ أدوية أخرى بما فيها تلك التي تشتريها بدون وصفة طبيّة وتتضمّن الأدوية العشبيّة. هذا لأنّ هيدروكـسيكلوروكين ساجا يمكن أن يؤثّر على مفعول بعض الأدوية الأخرى كما أنّ بعض الأدوية يمكن أن تؤثّر على مفعول هيدروكـسيكلوروكين ساجا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>بصورة خاصة أعلم الطبيب إذا كنت تأخذ أيًّا من الأدوية التالية</strong><strong>:</strong></p><p dir="RTL"><strong>الأدوية التالية يمكن أن تزيد خطر تعرّضك لتأثيرات&nbsp; جانبيّة عندما تؤخذ بالتزامن مع هيدروكـسيكلوروكين ساجا</strong><strong>:</strong></p><p dir="RTL">- بعض المضادات الحيويّة المستعملة لعلاج حالات العدوى (مثل الجنتاميسين أو النيوميسين أو التوبراميسين)</p><p dir="RTL">- السيميتيدين المستعمل لقرحة المعدة</p><p dir="RTL">- النيوستيغمين والبيريدوستيغمين المستعملان للضعف العضلي (الوهن العضلي الوبيل)</p><p dir="RTL">- الأدوية التي قد تؤثّر على الكليتين أو الكبد</p><p dir="RTL">- الأدوية التي تؤثّر على الجلد أو العينين</p><p dir="RTL">- الأدوية المستعملة لعلاج الملاريا (مثل الهالوفانتين، الميفلوكين، الموكسيفلوكساسين)</p><p dir="RTL">- بعض الأدوية المستعملة لعلاج عدم انتظام ضربات القلب (الأميودارون)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية التالية قد تغيّر مفعول هيدروكـسيكلوروكين ساجا أو قد يؤثّر هيدروكـسيكلوروكين ساجا على مفعول بعض هذه الأدوية</strong><strong>:</strong></p><p dir="RTL">- الديجوكسين &ndash; المستعمل لمشاكل القلب</p><p dir="RTL">- أدوية الصرع</p><p dir="RTL">- أدوية السكّري (مثل الأنسولين أو المتفورمين)</p><p dir="RTL">- مضادات الحموضة &ndash; المستعملة لحرقة المعدة أو عسر الهضم. يجب عليك ترك 4 ساعات على الأقلّ بين أخذ هذه الأدوية وهيدروكـسيكلوروكين ساجا</p><p dir="RTL">- لقاح الكَلَب</p><p dir="RTL">- البرازيكوانتيل</p><p dir="RTL">- السيكلوسبورين</p><p dir="RTL">-&nbsp; الأغالسيداز</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والإرضاع</strong></p><p dir="RTL"><strong>لا تتناولي هيدروكـسيكلوروكين ساجا إذا</strong><strong>:</strong></p><p dir="RTL">- كنتِ حاملاً أو قد تصبحين حاملاً أو تعتقدين نفسكِ حاملاً</p><p dir="RTL">- كنتِ تُرضعين أو تنوين الإرضاع، لأنّ كميّات صغيرة من الدواء قد تعبر إلى حليب الأم.</p><p dir="RTL">- استشري الطبيب أو الصيدلي قبل تناول أيّ دواء إذا كنتِ حاملاً أو مرضعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قيادة السيّارات واستعمال الآلات</strong></p><p dir="RTL">قد تتعرّض لمشاكل بصريّة خلال فترة العلاج بهذا الدواء. في هذه الحالة لا تقد السيّارة ولا تستعمل أيّ أدوات أو آلات وأعلم الطبيب على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات مهمّة حول بعض مكوّنات هيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">يحتوي هذا الدواء على اللاكتوز. إذا قال لك طبيبك إنّك لا تتحمّل بعض أنواع السكّر، تحدّث إليه قبل تناول هيدروكـسيكلوروكين ساجا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هيدروكـسيكلوروكين ساجا دائمًا حسب وصفة الطبيب.</p><p dir="RTL">سوف يقرّر طبيبك جرعتك اليوميّة. يجب عليك التحقّق مع الطبيب أو الصيدلي إذا لم تكن متأكّدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية تناول دواء هيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">&bull; تناول الدواء عن طريق الفم</p><p dir="RTL">&bull; إبلع الأقراص كاملة مع الطعام أو مع كوب حليب. لا تسحق الأقراص ولا تمضغها</p><p dir="RTL">&bull; إذا كنت تأخذ هذا الدواء لمشاكل جلديّة حسّاسة تجاه أشعّة الشمس، لا تأخذه إلا في خلال فترات التعرّض الكثيف للنور</p><p dir="RTL">&bull; سوف يحدّد الطبيب الجرعة حسب وزنك. إذا شعرت أنّ مفعول دوائك ضعيف جدًّا أو قويّ جدًّا، لا تعدّل الجرعة من تلقاء نفسك بل اسأل الطبيب.</p><p dir="RTL">&bull; إذا كنت تأخذ هذا الدواء لالتهاب المفاصل الروماتويدي لمدّة طويلة (أكثر من 6 أشهر) ولا تشعر أنّه يساعدك، راجع الطبيب. هذا لأنّه قد يكون من الضروريّ إيقاف العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>مقدار الجرعة</strong></p><p dir="RTL"><strong>البالغون بمن فيهم المسنّون</strong></p><p dir="RTL">قرص أو قرصان كلّ يوم</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">قرص واحد كلّ يوم</p><p dir="RTL">يناسب هذا الدواء الأطفال الذين يفوق وزنهم 35 كلغ.</p><p dir="RTL">قد تمرّ أسابيع عدّة قبل أن تلاحظ أيّ منفعة من أخذ هيدروكـسيكلوروكين ساجا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أخذت جرعة مفرطة من هيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">إذا أخذت جرعة مفرطة من هيدروكـسيكلوروكين ساجا، أعلم الطبيب أو اذهب على الفور إلى قسم الطوارئ في المستشفى. خذ علبة الدواء معك، لكي يعرف الطبيب ماذا أخذت.</p><p dir="RTL">قد تُصاب بالتأثيرات التالية: صداع، مشاكل في النظر، هبوط في ضغط الدم، اختلاجات (نوبات)، مشاكل قلبيّة، تتبعها مشاكل حادّة في التنفّس ونوبة قلبيّة ربّما. قد تسبّب الجرعة المفرطة من هيدروكـسيكلوروكين ساجا الوفاة.</p><p dir="RTL">يتعرّض الأولاد الصغار والأطفال لخطر كبير إذا أخذوا هيدروكـسيكلوروكين ساجا عن طريق الخطأ. خذ الطفل إلى المستشفى على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت أن تتناول هيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">إذا نسيت تناول جرعة، تناولها حالما تتذكّر. ولكن إذا كان سيحين وقت الجرعة التالية، فوّت الجرعة التي نسيتها. لا تأخذ جرعة مضاعفة للتعويض عن الجرعة التي نسيت أخذها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقّفت عن تناول هيدروكـسيكلوروكين ساجا</strong></p><p dir="RTL">واصل تناول دوائك إلى أن يطلب منك الطبيب التوقّف عن تناوله. لا تتوقّف عن تناول هيدروكـسيكلوروكين ساجا لأنّك تشعر بالتحسّن. إذا توقّفت عن تناول الدواء، قد يسوء مرضك مجدّدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كان لديك أيّ أسئلة أخرى حول استعمال هذا الدواء، اسأل الطبيب أو الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل الأدوية كلّها، يمكن أن يسبّب هيدروكـسيكلوروكين ساجا تأثيرات جانبيّة لا تُصيب المرضى كلّهم.</p><p dir="RTL"><strong>توقّف عن تناول هيدروكـسيكلوروكين ساجا واذهب عند الطبيب أو إلى المستشفى على الفور إذا</strong><strong>:</strong></p><p dir="RTL">&bull; تعرّضت لارتكاس تحسّسي. قد تتضمّن العوارض: طفح أحمر أو كتل، مشاكل في البلع أو التنفّس، تورّم الجفنين أو الشفتين أو الوجه أو الحلق أو اللسان.</p><p dir="RTL"><strong>توقّف عن تناول هيدروكـسيكلوروكين ساجا واذهب عند الطبيب على الفور إذا لاحظت أيًّا من التأثيرات&nbsp; الخطيرة التالية فقد تحتاج إلى علاج طبّي طارئ</strong><strong>:</strong></p><p dir="RTL">&bull; تراود عددًا صغيرًا من الأشخاص المعالجين بهيدروكـسيكلوروكين ساجا أفكار لإلحاق الأذى بأنفسهم أو للانتحار. إذا راودتك هذه الأفكار في أيّ وقت، اتصل بطبيبك على الفور.</p><p dir="RTL">&bull; إذا أصبت بمشاكل في العينين تتضمّن تغييرًا في لون عينيك ومشاكل في نظرك مثل ضبابيّة الرؤية والحساسيّة تجاه الضوء أو الطريقة التي ترى بها الألوان.</p><p dir="RTL">&bull; إذا أصبت بضعف أو بتشنّجات أو بتيبّس أو بتقلّصات في العضلات أو بتغييرات في الإحساس مثل الوخز.</p><p dir="RTL">&bull; إذا كنت تتناول هذا الدواء لوقت طويل، سوف يفحص طبيبك من وقت لآخر عضلاتك وأوتارك للتأكّد من أنّها تعمل كما يجب.&nbsp;</p><p dir="RTL">&bull; ارتكاسات جلديّة حادة مثل التبثّر وتقشّر الجلد على نطاق واسع وبقع مليئة بالقيح مع حرارة مرتفعة.</p><p dir="RTL">&bull; تبثّر أو تقشّر الجلد حول الشفتين والعينين والفم والأنف والأعضاء التناسليّة وعوارض شبيهة بعوارض الانفلوانزا وحمى. يمكن أن تكون هذه حالة تُسمّى متلازمة ستيفنز-جونسون.</p><p dir="RTL">&bull; آفات جلديّة متعددة، حكّة جلديّة، ألم في المفاصل، حمى وشعور عام بالمرض. يمكن أن تكون هذه حالة تُسمّى النكروز الجلديّ السام.</p><p dir="RTL">&bull; قد تُصاب بحالات عدوى بسهولة أكثر من العادة. يمكن أن يكون السبب خمود نخاع العظم أو اضطراب في الدم يُسمّى &quot;ندرة المحببات&quot;.</p><p dir="RTL">&bull; قد تُصاب بتأثيرات كدمات بسهولة أكثر من العادة. قد يكون السبب مشكلة في الدم تُسمّى &quot;قلّة الصفيحات&quot;.</p><p dir="RTL">&bull; إذا شعرت بتعب أو أُغميَ عليك أو شعرت بدوار أو أصبح لون جلدك شاحبًا. قد تكون هذه عوارض اضطراب يُسمّى &quot;فقر الدم&quot;.&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; إذا شعرت بضعف أو بضيق نفس أو أصبحت تُصاب بتأثيرات&nbsp; كدمات وبحالات عدوى بسهولة أكثر من العادة. قد تكون هذه عوارض اضطراب يُسمّى &quot;فقر الدم اللاتنسّجي&quot;.</p><p dir="RTL">&bull; مشاكل في الكبد قد تسبّب اصفرار العينين أو الجلد (يرقان).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعلم الطبيب أو الصيدلي إذا تفاقم أحد التأثيرات الجانبيّة التالية أو دام لأكثر من بضعة أيّام</strong><strong>:</strong></p><p dir="RTL">&bull; طفح جلديّ، حكّة، تغييرات في لون جلدك أو داخل أنفك أو فمك.</p><p dir="RTL">&bull; الصدفيّة (بقع متقشّرة حمراء على الجلد تُصيب عادة الركبتين والمرفقين وفروة الرأس).</p><p dir="RTL">&bull; تساقط الشعر أو فقدان لون الشعر.</p><p dir="RTL">&bull; غثيان أو تقيّؤ، إسهال، فقدان الشهيّة (قهم) أو ألم في المعدة.</p><p dir="RTL">&bull; الشعور بعصبيّة، طنين في الأذن، فقدان السمع، صداع، نوبات، مشاكل في التوازن (دوخة) أو الشعور بدوار، مشاكل عقليّة (مثل الأوهام أو الهلوسات أو تغييرات في المزاج).</p><p dir="RTL">&bull; ضعف في عضلة القلب (اعتلال عضلة القلب) يسبّب صعوبة في التنفّس وسعالاً وارتفاع ضغط الدم وتورّمًا وزيادة معدّل ضربات القلب وانخفاض كميّة البول.</p><p dir="RTL">&bull; قد تُصاب بحالات عدوى بسهولة أكثر من العادة. يمكن أن يكون السبب خمود نخاع العظم.</p><p dir="RTL">&bull; عوارض حالة تُسمّى &quot;برفيريّة&quot; قد تتضمّن ألم المعدة والتقيّؤ ونوبات وظهور بثور وحكّة.</p><p dir="RTL">&bull; عوارض انخفاض مستوى غلوكوز الدم (نقص سكّر الدم). قد تشعر بعصبيّة أو برجفة أو بتعرّق.&nbsp;&nbsp;&nbsp;</p><p dir="RTL">&bull; رجفة، تشنّج عضلي، أو حركات متشنّجة غير منتظمة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>فحوصات الدم</strong></p><p dir="RTL">&bull; يُنصح بإجراء تعدادات دوريّة للدم للمرضى المعالجين بهيدروكـسيكلوروكين ساجا لوقت طويل ويجب إيقاف العلاج بهيدروكـسيكلوروكين ساجا في حال كانت نتائج الفحوصات غير طبيعيّة.&nbsp;</p><p dir="RTL">&bull; قد يُظهر فحص الدم تغييرات في طريقة عمل الكبد وأحيانًا قد يتوقّف الكبد عن العمل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ هذا الدواء بعيدًا عن متناول ورؤية الأطفال.</p><p dir="RTL">- لا يُستعمل هذا الدواء بعد انتهاء تاريخ الصلاحية الموضح على العلبة بعد كلمة EXP. يشير انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">- يُحفظ في درجة حرارة لا تتعدى 3٠ درجة مئوية.</p><p dir="RTL">- يُحفظ في العبوة الأصلية بعيدًا عن الضوء والرطوبة.</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف الصحي أو القمامة المنزلية. اسأل الصيدلاني عن طريقة التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>المادة الفعالة هي</strong><strong>:</strong></p><p dir="RTL">هيدروكسيكلوروكين. يحتوي كل قرص مغلف على 200 ملج هيدروكسيكلوروكين</p><p dir="RTL"><strong>المكونات الأخرى هي</strong><strong>:</strong></p><p dir="RTL">-نشا الذرة</p><p dir="RTL">-بوليفينيل بيروليدون (بوفيدون K30)</p><p dir="RTL">- مونوهيدرات اللاكتوز</p><p dir="RTL">-ستيرات المغنيسيوم</p><p dir="RTL">-اوبادراي II أبيض 32F280000</p><p>- ماء مقطر</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- هيدروكـسيكلوروكين ساجا هو قرص أبيض دائري الشكل ومحدب من الجانبين مع نقش من جانب واحد بالرمز &quot;E&quot;.</p><p dir="RTL">- يتوفر هيدروكـسيكلوروكين ساجا في عبوة تحتوي على 60 قرصًا في شرائط من PVC-PVDC\Alu (الشريط به 15 قرص)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ساجا الصيدلانية</p><p dir="RTL">الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة</p><p dir="RTL">جدة &ndash; المملكة العربية السعودية</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية</strong></p><p dir="RTL"><strong>&bull; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL">- المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL">- مركز اتصالات الهيئة العامة للغذاء والدواء السعودية : 19999</p><p dir="RTL">- البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">- الموقع الإلكتروني:&nbsp; https://ade.sfda.gov.sa</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; <strong>دول الخليج الأخرى/ الدول الأخرى</strong></p><p dir="RTL">- الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ديسمبر/٢٠٢٣
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hydroxychloroquine SAJA 200mg film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hydroxychloroquine sulfate 200mg
Excipients with known effect
Each tablet contains 27 mg of lactose.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults<br />Treatment of rheumatoid arthritis, discoid and systemic lupus erythematosus, and dermatological conditions<br />caused or aggravated by sunlight.<br />Paediatric Population<br />Treatment of juvenile idiopathic arthritis (in combination with other therapies), discoid and systemic lupus<br />erythematosus.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults (including the elderly)<br />The minimum effective dose should be employed. This dose should not exceed 6.5mg/kg/day (calculated from<br />ideal body weight and not actual body weight) and will be either 200mg, 300mg or 400mg per day.<br />In patients able to receive 400mg daily:<br />Initially 400mg daily in divided doses. The dose can be reduced to 200mg when no further improvement is<br />evident. The maintenance dose should be increased to 300mg or 400mg daily if the response lessens.<br />Paediatric Population<br />The minimum effective dose should be employed and should not exceed 6.5mg/kg/day based on ideal body<br />weight. The 200mg tablet is therefore not suitable for use in children with an ideal body weight of less than<br />31kg.<br />Each dose should be taken with a meal or glass of milk.<br />Hydroxychloroquine is cumulative in action and will require several weeks to exert its beneficial effects,<br />whereas minor side effects may occur relatively early. For rheumatic disease treatment should be discontinued<br />if there is no improvement by 6 months. In light-sensitive diseases, treatment should only be given during<br />periods of maximum exposure to light.<br />The tablets are for oral administration.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • hypersensitivity to hydroxychloroquine or to any of the excipients
• known hypersensitivity to 4-aminoquinoline compounds
• pre-existing maculopathy of the eye
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Visual Effects<br />The occurrence of retinopathy is very uncommon if the recommended daily dose is not exceeded. The<br />administration of doses in excess of the recommended maximum is likely to increase the risk of retinopathy,<br />and accelerate its onset.<br />All patients should have an ophthalmological examination before initiating treatment with Hydroxychloroquine.<br />Thereafter, ophthalmological examinations must be repeated at least every 12 months.<br />The examination should include testing visual acuity, careful ophthalmoscopy, fundoscopy, central visual field<br />testing with a red target, and colour vision.<br />This examination should be more frequent and adapted to the patient in the following situations:<br />o daily dosage exceeds 6.5mg/kg lean body weight. Absolute body weight used as a guide to dosage could<br />result in an overdosage in the obese<br />o renal insufficiency<br />o visual acuity below 6/8<br />o age above 65 years<br />o cumulative dose more than 200g.<br />Hydroxychloroquine should be discontinued immediately in any patient who develops a pigmentary<br />abnormality, visual field defect, or any other abnormality not explainable by difficulty in accommodation or<br />presence of corneal opacities. Patients should continue to be observed for possible progression of the<br />changes.<br />Patients should be advised to stop taking the drug immediately and seek the advice of their prescribing doctor if<br />any disturbances of vision are noted, including abnormal colour vision.<br />Cardiac Effects<br />Cases of cardiomyopathy resulting in cardiac failure, in some cases with fatal outcome, have been reported in<br />patients treated with Hydroxychloroquine (see section 4.8 and 4.9). Clinical monitoring for signs and symptoms<br />of cardiomyopathy is advised and Hydroxychloroquine should be discontinued if cardiomyopathy develops.<br />Chronic toxicity should be considered when conduction disorders (bundle branch block / atrio-ventricular heart<br />block) as well as biventricular hypertrophy are diagnosed (see section 4.8).<br />Caution is required in the following circumstances<br />Hydroxychloroquine should be used with caution in patients taking medicines which may cause adverse ocular<br />or skin reactions.<br />Carefully consider the benefits and risks before prescribing hydroxychloroquine for any patients taking<br />azithromycin or other macrolide antibiotics, because of the potential for an increased risk of cardiovascular<br />events and cardiovascular mortality (see section 4.5).<br />Caution should also be applied when it is used in the following:<br />o patients with hepatic or renal disease, and in those taking drugs known to affect those organs. Estimation of<br />plasma hydroxychloroquine levels should be undertaken in patients with severely compromised renal or hepatic<br />function and dosage adjusted accordingly.<br />o patients with severe gastrointestinal, neurological or blood disorders.<br />o caution is also advised in patients with a sensitivity to quinine, those with glucose-6-phosphate<br />dehydrogenase deficiency, those with porphyria cutanea tarda which can be exacerbated by<br />hydroxychloroquine and in patients with psoriasis since it appears to increase the risk of skin reactions.<br />o patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucosegalactose malabsorption should not take this medicine.<br />Blood Disorders<br />Although the risk of bone marrow depression is low, periodic blood counts are advisable as anaemia, aplastic<br />anaemia, agranulocytosis, a decrease in white blood cells, and thrombocytopenia have been reported.<br />Hydroxychloroquine sulfate should be discontinued if abnormalities develop.<br />Toxic effects in children<br />Small children are particularly sensitive to the toxic effects of 4-aminoquinolines; therefore patients should be<br />warned to keep Hydroxychloroquine sulfate out of the reach of children.<br />Hypoglycaemia<br />Hydroxychloroquine has been shown to cause severe hypoglycaemia including loss of consciousness that<br />could be life threatening in patients treated with and without antidiabetic medications. Patients treated with<br />hydroxychloroquine should be warned about the risk of hypoglycaemia and the associated clinical signs and<br />symptoms. Patients presenting with clinical symptoms suggestive of hypoglycaemia during treatment with<br />hydroxychloroquine should have their blood glucose level checked and treatment reviewed as necessary.<br />Muscoskeletal effects<br />All patients on long-term therapy should undergo periodic examination of skeletal muscle function and tendon<br />reflexes. If weakness occurs, the drug should be withdrawn.<br />Dermatological reactions<br />Life-threatening cutaneous reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)<br />have been reported with the use of Hydroxychloroquine.<br />Patients should be advised of the signs and symptoms and if symptoms or signs of SJS or TEN are present,<br />Hydroxychloroquine treatment should be discontinued.<br />If the patient has developed SJS or TEN with the use of Hydroxychloroquine, Hydroxychloroquine must not be<br />restarted in this patient at any time<br />Extrapyramidal disorders<br />Extrapyramidal disorders may occur with Hydroxychloroquine sulfate (see section 4.8).<br />Suicidal behaviour and psychiatric disorders<br />Suicidal behaviour and psychiatric disorders have been reported in some patients treated with<br />hydroxychloroquine (see section 4.8). Psychiatric side effects typically occur within the first month after the start<br />of treatment with hydroxychloroquine and have been reported also in patients with no prior history of psychiatric<br />disorders. Patients should be advised to seek medical advice promptly if they experience psychiatric symptoms<br />during treatment.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Digoxin<br />Hydroxychloroquine sulfate has been reported to increase plasma digoxin levels: serum digoxin levels should<br />be closely monitored in patients receiving combined therapy.<br />Chloroquine<br />Hydroxychloroquine sulfate may also be subject to several of the known interactions of chloroquine even<br />though specific reports have not appeared. These include: potentiation of its direct blocking action at the<br />neuromuscular junction by aminoglycoside antibiotics; inhibition of its metabolism by cimetidine which may<br />increase plasma concentration of the antimalarial; antagonism of effect of neostigmine and pyridostigmine;<br />reduction of the antibody response to primary immunisation with intradermal human diploid-cell rabies vaccine.<br />Antacids<br />As with chloroquine, antacids may reduce absorption of hydroxychloroquine so it is advised that a 4 hour<br />interval be observed between Hydroxychloroquine sulfate and antacid dosaging.<br />Anti-diabetics<br />As hydroxychloroquine may enhance the effects of a hypoglycaemic treatment, a decrease in doses of insulin<br />or antidiabetic drugs may be required.<br />Halofantrine<br />Halofantrine prolongs the QT interval and should not be administered with other drugs that have the potential to<br />induce cardiac arrhythmias, including hydroxychloroquine. Also, there may be an increased risk of inducing<br />ventricular arrhythmias if hydroxychloroquine is used concomitantly with other arrhythmogenic drugs, such as<br />amiodarone and moxifloxacin.<br />Ciclosporin<br />An increased plasma ciclosporin level was reported when ciclosporin and hydroxychloroquine were coadministered.<br />Tamoxifen<br />Concomitant use of drugs known to induce retinal toxicity, e.g. tamoxifen and hydroxychloroquine sulfate, is not<br />recommended (see section 4.4).<br />Antimalarials<br />Hydroxychloroquine can lower the convulsive threshold. Co-administration of hydroxychloroquine with other<br />antimalarials known to lower the convulsion threshold (e.g mefloquine) may increase the risk of convulsions.<br />Antiepileptics<br />Also, the activity of antiepileptic drugs might be impaired if co-administered with hydroxychloroquine.<br />Praziquantil<br />In a single-dose interaction study, chloroquine has been reported to reduce the bioavailability of praziquantel. It<br />is not known if there is a similar effect when hydroxychloroquine and praziquantel are coadministered. Per<br />extrapolation, due to the similarities in structure and pharmacokinetic parameters between hydroxychloroquine<br />and chloroquine, a similar effect may be expected for hydroxychloroquine.<br />Agalsidase<br />There is a theoretical risk of inhibition of intra-cellular &alpha;-galactosidase activity when hydroxychloroquine is coadministered with agalsidase.<br />Azithromycin and macrolide antibiotics<br />Observational data have shown that co-administration of hydroxychloroquine with azithromycin in patients with<br />rheumatoid arthritis is associated with an increased risk of cardiovascular events and cardiovascular mortality.<br />Carefully consider the balance of benefits and risks before prescribing hydroxychloroquine for any patients<br />taking azithromycin. Similar careful consideration of the balance of benefits and risks should also be<br />undertaken before prescribing hydroxychloroquine for any patients taking other macrolide antibiotics, such as<br />clarithromycin or erythromycin, because of the potential for a similar risk when hydroxychloroquine is coadministered with these medicines.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>FDA Pregnancy Category N - Not classified<br />Fertility:<br />There is no information available on the effect of Hydroxychloroquine sulfate on human fertility. In animal<br />studies, chloroquine, a substance related to hydroxychloroquine, showed adverse effects on male fertility (see<br />section 5.3).<br />Pregnancy:<br />Although able to cross the placenta, the use of hydroxychloroquine in pregnancy is now considered to convey a<br />low risk of harm to the foetus with no significant increase in congenital malformations. In SLE there is evidence<br />that hydroxychloroquine reduces disease activity during pregnancy reinforcing the importance of continuing this<br />therapy. Indeed, pregnancy itself can induce lupus flares, which can be prevented by hydroxychloroquine.<br />Preliminary studies have suggested that hydroxychloroquine can reduce the risk of neonatal lupus and<br />congenital heart block in lupus patients who are anti-Ro positive. A recently published study of pregnant<br />patients with antiphospholipid syndrome found that exposure to hydroxychloroquine was linked to a significantly<br />higher live birth rate.<br />Taken together in autoimmune diseases such as lupus and anti-phospholipid syndrome the balance of benefit<br />outweighs any potential harm to the foetus and therefore hydroxychloroquine should be continued. In other<br />diseases the prescribing physician should assess the risk/benefit ratio for hydroxychloroquine and act<br />accordingly.<br />Lactation:<br />Data on safety during breastfeeding are limited but no harmful effects have been observed.<br />Hydroxychloroquine is excreted in small amounts in breast milk, with estimates of exposure to infants ranging<br />from &lt;1% to about 3% of the adult dose. All infants exposed to hydroxychloroquine during pregnancy will also<br />have been exposed during breastfeeding because the half-life of hydroxychloroquine is more than 40 days.<br />Hydroxychloroquine seems to carry a low risk of harm to the infant. A careful benefit-risk assessment should be<br />made whether to take hydroxychloroquine therapy whilst breastfeeding, taking into account the benefit of<br />breastfeeding for the child and the benefit of therapy for the woman.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Impaired visual accommodation soon after the start of treatment has been reported and patients should be<br />warned regarding driving or operating machinery. If the condition is not self-limiting, it will resolve on reducing<br />the dose or stopping treatment.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>a.&nbsp; </strong><strong><u>Summary of the safety profile</u></strong></p><p>The following CIOMS frequency rating is used, when applicable:</p><p>Very common (&ge;1/10); Common(&ge;1/100 to &lt;1/10) ; Uncommon(&ge;1/1,000 to &lt;1/100) ; Rare(&ge;1/10,000 to</p><p>&lt;1/1,000); Very rare (&lt;1/10,000) ; Not known (cannot be estimated from the available data).</p><p>b.&nbsp; Tabulated list of adverse reactions</p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Immune </em><em>system disorders</em></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Urticaria, angioedema, bronchospasm</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Eye disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Blurring of vision due to a disturbance of accommodation which is dose dependent and reversible</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Retinopathy with changes in pigmentation and visual field defects can occur, but appears to be uncommon if the recommended daily dose is not exceeded. In its early form it appears reversible on discontinuation of hydroxychloroquine sulfate. If allowed to develop, there may be a risk of progression even after treatment withdrawal. Patients with retinal changes may be asymptomatic initially, or may have scotomatous vision with paracentral, pericentral ring types, temporal scotomas and abnormal colour vision.</p><p>Corneal changes including oedema and opacities have been reported. They are either symptomless or may cause disturbances such as haloes, blurring of vision or photophobia. They may be transient and are reversible on stopping treatment.</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Cases of maculopathies and macular degeneration have been reported (the onset ranging from 3 months to several years of exposure to hydroxychloroquine) and may be irreversible</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Skin rash, Pruritus</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Pigmentary disorders in skin and mucous membranes, bleaching of hair, alopecia</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>These usually resolve readily on stopping treatment.</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Bullous eruptions including erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS syndrome) photosensitivity, exfoliative dermatitis, acute generalised exanthematous pustulosis (AGEP).</p><p>Acute generalised exanthematous pustulosis (AGEP) has to be distinguished from psoriasis, although hydroxychloroquine may precipitate attacks of psoriasis. It may be associated with fever and hyperleukocytosis. Outcome is usually favourable after drug withdrawal.</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Gastrointestinal</em><em> </em><em>disorders</em></p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Abdominal pain, nausea</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>diarrhoea, vomiting</p><p>These symptoms usually resolve immediately on reducing the dose or on stopping treatment.</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Nervous system disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Headache</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dizziness</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Convulsions have been reported with this class of drugs. Extrapyramidal disorders such as dystonia, dyskinesia, tremor (see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p><em>Cardiac disorders</em></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Cardiomyopathy which may result in cardiac failure and in some cases a fatal outcome (see SPC section 4.4 and 4.9)</p><p>Chronic toxicity should be considered when conduction disorders (bundle branch block/atrioventricular heart block) as well as biventricular hypertrophy are found. Drug withdrawal may lead to recovery.</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Musculoskeletal and connective tissue disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Sensory motor disorders</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Skeletal muscle myopathy or neuromyopathy leading to progressive weakness and atrophy of proximal muscle groups.</p><p>Myopathy may be reversible after drug discontinuation, but recovery may take many months.</p><p>Depression of tendon reflexes and abnormal nerve conduction studies.</p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and lymphatic system disorders</em></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Bone-marrow depression, anaemia, aplastic anaemia, agranulocytosis, leucopenia and thrombocytopenia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Hepatobiliary disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Abnormal liver function tests</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Fulminant hepatic failure</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Metablism and nutrition disorders</em></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypoglycaemia (see section 4.4),</p><p>Hydroxychloroquine may precipitate or exacerbate porphyria.</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><em>Ear and labyrinth disorders</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Vertigo, tinnitus</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hearing loss</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Psychiatric disorders</em></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Affect lability</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Nervousness</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Psychosis, suicidal behaviour, depression, hallucinations, anxiety, agitation, confusion, delusions, mania and sleep disorders.</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>c.&nbsp; </strong><strong><u>Description of selected side effects</u></strong></p><p>&nbsp;</p><p>Not applied</p><p>d.&nbsp; Special populations</p><p><strong>&nbsp;</strong></p><p>Not applied</p><p>e.&nbsp; Paediatric population</p><p><strong>Not applied</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>Saudi Arabia</p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t202" style='position:absolute;
  margin-left:72.25pt;margin-top:7.35pt;width:280pt;height:53.65pt;z-index:-15728640;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' filled="f" strokeweight=".48pt">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:12.35pt;margin-bottom:.0001pt;text-indent:-7.25pt;
     mso-list:l1 level1 lfo1;tab-stops:12.4pt'><![if !supportLists]><span
     style='font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-font-width:99%'><span style='mso-list:Ignore'>•<span
     style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span
     dir=LTR></span><span style='font-size:10.0pt;mso-bidi-font-size:11.0pt;
     font-family:"Calibri",sans-serif;mso-hansi-font-family:Arial;mso-bidi-font-family:
     Arial'>The<span style='letter-spacing:-.25pt'> </span>National<span
     style='letter-spacing:-.15pt'> </span>Pharmacovigilance<span
     style='letter-spacing:-.25pt'> </span>Centre<span style='letter-spacing:
     -.2pt'> </span>(NPC)<o:p></o:p></span></p>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:12.35pt;margin-bottom:.0001pt;text-indent:-7.25pt;
     line-height:12.15pt;mso-line-height-rule:exactly;mso-list:l1 level1 lfo1;
     tab-stops:12.4pt'><![if !supportLists]><span style='font-size:10.0pt;
     font-family:"Calibri",sans-serif;mso-fareast-font-family:Calibri;
     mso-font-width:99%'><span style='mso-list:Ignore'>•<span style='font:7.0pt "Times New Roman"'>
     </span></span></span><![endif]><span dir=LTR></span><span
     style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
     mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'>SFDA<span
     style='letter-spacing:-.1pt'> </span>Call<span style='letter-spacing:-.15pt'>
     </span>Center:<span style='letter-spacing:-.25pt'> </span>19999<o:p></o:p></span></p>
     <p class=MsoNormal style='margin-left:12.35pt;text-indent:-7.25pt;
     line-height:12.15pt;mso-line-height-rule:exactly;mso-list:l1 level1 lfo1;
     tab-stops:12.4pt'><![if !supportLists]><span style='font-size:10.0pt;
     font-family:"Calibri",sans-serif;mso-fareast-font-family:Calibri;
     mso-font-width:99%'><span style='mso-list:Ignore'>•<span style='font:7.0pt "Times New Roman"'>
     </span></span></span><![endif]><span dir=LTR></span><span
     style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
     mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'>E-mail:<span
     style='letter-spacing:-.3pt'> </span></span><a
     href="mailto:npc.drug@sfda.gov.sa"><span style='font-size:10.0pt;
     mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;mso-hansi-font-family:
     Arial;mso-bidi-font-family:Arial;color:windowtext;text-decoration:none;
     text-underline:none'>npc.drug@sfda.gov.sa</span></a><span
     style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
     mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'><o:p></o:p></span></p>
     <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
     0in;margin-left:12.35pt;margin-bottom:.0001pt;text-indent:-7.25pt;
     mso-list:l1 level1 lfo1;tab-stops:12.4pt'><![if !supportLists]><span
     style='font-size:10.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-font-width:99%'><span style='mso-list:Ignore'>•<span
     style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span
     dir=LTR></span><span style='font-size:10.0pt;mso-bidi-font-size:11.0pt;
     font-family:"Calibri",sans-serif;mso-hansi-font-family:Arial;mso-bidi-font-family:
     Arial'>Website:<span style='letter-spacing:-.3pt'> </span>https://ade.sfda.gov.sa<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="380" height="78" alt="Text Box: •	The National Pharmacovigilance Centre (NPC)
•	SFDA Call Center: 19999
•	E-mail: npc.drug@sfda.gov.sa
•	Website: https://ade.sfda.gov.sa
" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p><!--[if gte vml 1]></o:wrapblock><![endif]--></p><p>&nbsp;</p><p><strong>Other GCC states /other countries</strong></p><p><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:9.5pt;font-family:"Calibri",sans-serif;
mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'><span style='mso-element:
field-begin;mso-field-lock:yes'></span><span style='mso-spacerun:yes'> </span>SHAPE
<span style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:
field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:shape id="_x0000_s1026"
 type="#_x0000_t202" style='width:280pt;height:37.1pt;mso-left-percent:-10001;
 mso-top-percent:-10001;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:char;mso-position-vertical:absolute;
 mso-position-vertical-relative:line;mso-left-percent:-10001;mso-top-percent:-10001'
 filled="f" strokeweight=".48pt">
 <v:textbox inset="0,0,0,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoBodyText style='margin-top:.1pt;margin-right:0in;margin-bottom:
    0in;margin-left:0in;margin-bottom:.0001pt'><b style='mso-bidi-font-weight:
    normal'><span style='font-size:10.0pt;mso-bidi-font-size:9.5pt;font-family:
    "Calibri",sans-serif;mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'><o:p>&nbsp;</o:p></span></b></p>
    <p class=MsoNormal style='margin-left:5.15pt'><span style='font-size:10.0pt;
    mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;mso-hansi-font-family:
    Arial;mso-bidi-font-family:Arial'>-Please<span style='letter-spacing:-.25pt'>
    </span>contact<span style='letter-spacing:-.15pt'> </span>the<span
    style='letter-spacing:-.25pt'> </span>relevant<span style='letter-spacing:
    -.15pt'> </span>competent<span style='letter-spacing:-.2pt'> </span>authority.<o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:shape><![endif]--><img width="379" height="55" alt="Text Box: -Please contact the relevant competent authority.
" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:9.5pt;font-family:"Calibri",sans-serif;
mso-hansi-font-family:Arial;mso-bidi-font-family:Arial'><v:shape id="_x0000_i1025"
 type="#_x0000_t75" style='width:280pt;height:37.1pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage with the 4-aminoquinolines is dangerous particularly in infants, as little as 1-2g having proved fatal.</p><p>The symptoms of overdosage may include headache, visual disturbances, cardiovascular collapse, convulsions, hypokalaemia; rhythm and conduction disorders, including QT prolongation, Torsade de Pointes, ventricular tachycardia and ventricular fibrillation followed by sudden and early respiratory and cardiac arrest. Since these effects may appear soon after taking a massive dose, treatment should be prompt and symptomatic.</p><p>The stomach should be immediately evacuated, either by emesis or by gastric lavage. Activated charcoal in a dose at least five times of the overdose may inhibit further absorption if introduced into the stomach by tube following lavage and within 30 minutes of ingestion of the overdose.</p><p>Consideration should be given to administration of parenteral diazepam in cases of overdosage; it has been shown to be beneficial in reversing chloroquine cardiotoxicity.</p><p>Respiratory support and shock management should be instituted as necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>ATC Code: P01BA02</strong></p><p><strong>Pharmacotherapeutic group: Anti rheumatic</strong></p><p>Antimalarial agents like chloroquine and hydroxychloroquine have several pharmacological actions which may be involved in their therapeutic effect in the treatment of rheumatic disease, but the role of each is not known. These include interaction with sulphydryl groups, interference with enzyme activity (including phospholipase, NADH - cytochrome C reductase, cholinesterase, proteases and hydrolases), DNA binding, stabilisation of lysosomal membranes, inhibition of prostaglandin formation, inhibition of polymorphonuclear cell chemotaxis and phagocytosis, possible interference with interleukin 1 production from monocytes and inhibition of neutrophil superoxide release.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxychloroquine has actions, pharmacokinetics and metabolism similar to those of chloroquine. Following oral administration, hydroxychloroquine is rapidly and almost completely absorbed. In one study, mean peak plasma hydroxychloroquine concentrations following a single dose of 400mg in healthy subjects ranged from 53-208ng/ml with a mean of 105ng/ml. The mean time to peak plasma concentration was 1.83 hours. The mean plasma elimination half-life varied, depending on the post-administration period, as follows: 5.9 hours at Cmax-10&nbsp;hours), 26.1 hours (at 10-48 hours) and 299 hours (at 48-504 hours). The parent compound and metabolites are widely distributed in the body and elimination is mainly via the urine, where 3% of the administered dose was recovered over 24 hours in one study.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Animal studies concerning a cancerogenic potential of hydroxychloquine are not available. A mutagenic potential could not be excluded.</p><p>Hydroxychloroquine passes the placenta and can induce damage to organs of the fetus. In studies with mice and monkeys, chloroquine, a substance related to hydroxychloroquine, resulted in transplacental transfer and accumulation in the adrenal cortex and the retina. High maternal doses of chloroquine were fetotoxic in rats and caused anophthalmia and microophthalmia. In studies in rats, chloroquine reduced the testosterone secretion, the weight of the testis and epididymis and caused production of abnormal sperm.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-Corn Starch</p><p>-Polyvinyl Pyrolidone (Povidone K30)</p><p>-Lactose monohydrate</p><p>-Magnesium Stearate</p><p>-Opadry II white 32F280000</p><p>-Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>Store in the original package in order to protect from light and moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Available in packs containing 60 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAJA Pharmaceuticals, Jeddah, Saudi Arabia
 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dec.2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>